Literature DB >> 29345851

The immunosuppressive effects of CD4+ CD25+ regulatory T cells on dendritic cells in patients with chronic hepatitis B.

P Zhou1, J Xu1,2, M Dai1, Y Shi1, G Wu1, Y Fang1, X Yan1.   

Abstract

The characteristics and functions of CD4+ CD25+ regulatory T cells (Tregs) have been well defined in murine and human systems. However, the interaction or crosstalk between CD4+ CD25+ Tregs and dendritic cells (DCs) remains controversial. In this study, the effects of chronic hepatitis B (CHB) CD4+ CD25+ Tregs on the maturation and function of monocyte-derived DCs were examined. The results showed that CD4+ CD25+ render the DCs inefficient as antigen-presenting cells (APCs) despite prestimulation with CD40 ligand. This effect was marginally reverted by applying neutralizing antibodies (Abs) to IL-10 and TGF-β. There were an increased IL-10 and TGF-β secretion and reduced expression of costimulatory molecules in DC. Thus, in addition to a direct suppressor effect on CD4+ T cells, CD4+ CD25+ may modulate the immune response through DCs in CHB patients.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD4+CD25+ regulatory T cells (Tregs); chronic hepatitis B (CHB); dendritic cells (DCs); immune crosstalk

Mesh:

Substances:

Year:  2018        PMID: 29345851     DOI: 10.1111/jvh.12863

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  2 in total

1.  Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment.

Authors:  Chao Lu; Wanjin Fu; Renpeng Zhou; Wei Hu
Journal:  BMC Complement Med Ther       Date:  2020-02-05

2.  A New Antimalarial Noreudesmane Sesquiterpenoid from Dobinea delavayi.

Authors:  Xiu-Rong Wu; Yi Shen; Shu-Jun Cui; Xiao-Lei Luo; Chao-Jiang Xiao; Bei Jiang
Journal:  Nat Prod Bioprospect       Date:  2020-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.